Advertisement
Journal Home
Search for

Volume 59, Issue 3, Pages 217-223 (March 2006)


View previous. 3 of 17 View next.

Annualized was found better than absolute risk reduction in the calculation of number needed to treat in chronic conditions

Tracy J. MayneCorresponding Author Informationemail address, Edward Whalen, An Vu

Accepted 18 July 2005. published online 14 October 2005.

Abstract 

Background and Objective

Recent studies have calculated number needed to treat (NNT) estimates based on annualized rates; however, the ramifications of altering the NNT statistic have not yet been explored in the literature. Here we introduce the concept of annualized NNT (ANNT), and apply it to data from randomized controlled trials (RCTs).

Methods

Incidence rates from RCTs for serious adverse events for three medicines were compared to an older class of drugs. NNT and ANNT were calculated from the event rates for these events.

Results

Based on the data, the NNT to prevent one adverse event a year vs. older medications was drug A, ANNT = 88; drug B, ANNT = 77; drug C, ANNT = 68. Equivalent calculations based on Bayesian statistics are drug C, ANNT = 54; drug B, ANNT = 49. Drug A produced a bimodal distribution, with one mode within the NNT range and the other in the number needed to harm range.

Conclusions

NNT can erroneously inflate differences between treatments when based on absolute and not differential safety. We propose that NNT be limited to acute conditions with short-term, well-defined treatment courses, and that ANNT be used for chronic conditions.

Outcomes Research, Pfizer Pharmaceuticals, 235 East 42nd Street, 205/9/10, New York, NY 10017, USA

Corresponding Author InformationCorresponding author. Tel.: 212-733-6394; fax: 212-309-5294.

PII: S0895-4356(05)00247-7

doi:10.1016/j.jclinepi.2005.07.006


View previous. 3 of 17 View next.

Advertisement